Juniper Publishers: The Case for Drug Testing in Pediatric and Adolesc...

Juniper Publishers: The Case for Drug Testing in Pediatric and Adolesc...: Academic Journal of Pediatrics

Comments

  1. HegdeSeptember 9, 2019 at 4:06 AM


    Thank's for your information,Hear is the info of Hegde hospital, The best gynaecologist
    Best gynaecologist

    ReplyDelete

Post a Comment

Popular posts from this blog

Juniper Publishers : A Review of the Literature Evaluating Adherence and Persistence to Adjuvant Endocrine Therapy

Image
        JUNIPER PUBLISHERS- JOURNAL OF GYNECOLOGY AND WOMEN’S HEALTH                                    Journal of Gynecology and Women’s Health-Juniper Publishers   Authored by  Strickland KS*   Mini Review The use of adjuvant endocrine therapy (ET, e.g. tamoxifen or aromatase inhibitors: anastrozole, letrozole, exemestine) for five to ten years is the standard of care for individuals with hormone receptor positive breast cancer [ 1 ]. ET has resulted in impressive reductions in disease recurrence and mortality [ 2 ]. When taken as prescribed, these agents can reduce recurrence by 30-50% and reduce mortality by approximately one third irrespective of treatment with chemotherapy [ 2 , 3 ]. As evidence of the survival advantage of ET has mounted, taking the drug daily as direct...
Read more

Juniper Publishers : Administration of Tocolytic Agents is not Only un useful but also Culprit to Prevent Preterm Labor

Image
     JUNIPER PUBLISHERS- JOURNAL OF GYNECOLOGY AND WOMEN’S HEALTH                                    Journal of Gynecology and Women’s Health-Juniper Publishers   Authored by  Masamitsu Nakamura*   Abstract In Japan, long term tocolytic therapy for threatened preterm labor is still performed at many perinatal centers despite of less evidence for prevention against preterm delivery. There are some reports which tocolytic agents can prolong preterm delivery during antenatal corticosteroid therapy for maturation of fetal lung, or for maternal transport to a tertiary perinatal care center and which the administration of tocolytic agents to patients with threatened premature delivery was restricted due to side effects such as maternal lung edema or rhabdomyolysis. In addition to these si...
Read more